Abstract
Leptin may support the proliferation and hinder the apoptosis of tumor cells. Although leptin expression has been studied in several human tumors, its potential clinical significance remains uncertain in patients with gastric carcinoma. Furthermore, the majority of available findings have been determined from preclinical studies using stomach carcinoma tissue section and, to date, few studies have evaluated the clinical significance of leptin in the serum or plasma of gastric carcinoma patients. In the current study, the serum concentration of soluble leptin was assessed in gastric carcinoma patients, and its contributions to the clinical parameters and prognosis of patients were determined. A total of 63 pathologically confirmed gastric cancer patients and 30 healthy subjects were enrolled in the study and circulating leptin levels in the serum of all subjects were determined by ELISA. The serum leptin concentrations were significantly lower in the gastric cancer patients compared with the healthy control group (P = 0.009). In the gastric cancer patients, the clinical features of patient age, sex, lesion localization, histopathology, pathological grade, stage of disease, and serum tumor markers including lactate dehydrogenase, carcinoembryonic antigen, and carbohydrate antigen 19–9 were not correlated with serum leptin concentration. Furthermore, no association was observed between serum leptin concentration and responsiveness to chemotherapy (P = 0.51), and leptin level had no apparent prognostic role in clinical outcome (P = 0.57). In conclusion, although it was not predictive or prognostic, serum leptin level may be a valuable diagnostic indicator in patients with gastric carcinoma.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lee KN, Choi HS, Yang SY, et al. The role of leptin in gastric cancer: clinicopathologic features and molecular mechanisms. Biochem Biophys Res Commun 2014; 446: 822–9.
Geng Y, Wang J, Wang R, et al. Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients. Biomed Pharmacother 2012; 66: 419–24.
Zhao X, Huang K, Zhu Z, Chen S, Hu R. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer. J Gastroenterol Hepatol 2007; 22: 1317–21.
Ishikawa M, Kitayama J, Hagawa H. Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer. World J Gastroentereol 2006; 12: 5517–22.
Bain GH, Collie-Duguid E, Murray GI, et al. Tumour expression of leptin is associated with chemotherapy resistance and therapyindependent prognosis in gastro-oesophageal adenocarcinomas. Br J Cancer 2004; 110: 1525–34.
Bolukbas FF, Kilic H, Bolukbas C, et al. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004; 4:29.
Dülger H, Alici S, Şekeroğlu MR, et al. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer. Int J Clin Pract 2004; 58: 545–9.
Capelle LG, de Vries AC, Haringsma J, et al. Serum levels of leptin as marker for patients at high risk of gastric cancer. Helicobacter 2009; 14: 596–604.
Kemik O, Kemik AS, Begenik H, et al. The relationships among acute-phase response proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic. Hum Exp Toxicol 2011; 31: 117–25.
Kim EY, Chin HM, Park SM, et al. Susceptibility of gastric cancer according to leptin and leptin receptor gene polymorphisms inKorea. J Korean Surg Soc 2012; 83: 7–13.
Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med 2012; 33: 35–45.
Conde J, Scotece M, Abella V, et al. An update on leptin as immunomodulator. Expert Rev Clin Immunol 2014; 10: 1165–70.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tas, F., Karabulut, S., Erturk, K. et al. Clinical significance of serum leptin level in patients with gastric cancer. Eur Cytokine Netw 29, 52–58 (2018). https://doi.org/10.1684/ecn.2018.0408
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ecn.2018.0408